AcouSort
10.7 SEK 0%Be the first to follow this company
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Revenue
5.53M
EBIT %
-316.27 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACOU
Daily low / high price
10.7 / 10.7
SEK
Market cap
159.8M SEK
Turnover
2.55K SEK
Volume
238
Financial calendar
Interim report
2024-05-22
Interim report
2024-08-28
Interim report
2024-11-27
Annual report
2025-02-26
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.5 % | 10.5 % |
Thomas Laurell | 7.4 % | 7.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
AcouSort will exhibit and present at CYTO 2024 – demonstrating the benefits of acoustic sample preparation for flow cytometry applications
Kommuniké från årsstämma i AcouSort AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools